179 related articles for article (PubMed ID: 19887050)
1. EBV-induced human CD8(+) NKT cells synergise CD4(+) NKT cells suppressing EBV-associated tumours upon induction of Th1-bias.
Xiao W; Li L; Zhou R; Xiao R; Wang Y; Ji X; Wu M; Wang L; Huang W; Zheng X; Tan X; Chen L; Xiong T; Xiong J; Jin Y; Tan J; He Y
Cell Mol Immunol; 2009 Oct; 6(5):367-79. PubMed ID: 19887050
[TBL] [Abstract][Full Text] [Related]
2. EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies.
Yuling H; Ruijing X; Li L; Xiang J; Rui Z; Yujuan W; Lijun Z; Chunxian D; Xinti T; Wei X; Lang C; Yanping J; Tao X; Mengjun W; Jie X; Youxin J; Jinquan T
Cancer Res; 2009 Oct; 69(20):7935-44. PubMed ID: 19808969
[TBL] [Abstract][Full Text] [Related]
3. EBV promotes human CD8 NKT cell development.
He Y; Xiao R; Ji X; Li L; Chen L; Xiong J; Xiao W; Wang Y; Zhang L; Zhou R; Tan X; Bi Y; Jiang YP; Jin Y; Tan J
PLoS Pathog; 2010 May; 6(5):e1000915. PubMed ID: 20502687
[TBL] [Abstract][Full Text] [Related]
4. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
Merlo A; Turrini R; Bobisse S; Zamarchi R; Alaggio R; Dolcetti R; Mautner J; Zanovello P; Amadori A; Rosato A
J Immunol; 2010 May; 184(10):5895-902. PubMed ID: 20385879
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy.
He J; Tang XF; Chen QY; Mai HQ; Huang ZF; Li J; Zeng YX
Chin J Cancer; 2012 Jun; 31(6):287-94. PubMed ID: 22257383
[TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
Baxevanis CN; Gritzapis AD; Papamichail M
J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type.
Zanussi S; Vaccher E; Caffau C; Pratesi C; Crepaldi C; Bortolin MT; Tedeschi R; Politi D; Barzan L; Tirelli U; De Paoli P
Cancer Immunol Immunother; 2003 Jan; 52(1):28-32. PubMed ID: 12536237
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte subsets and Th1/Th2 cytokines in convalescent patients with Epstein-Barr virus-associated aplastic anemia.
Chen T; Chen Y; Bao W; Lu W
Hematology; 2020 Dec; 25(1):11-16. PubMed ID: 31842718
[No Abstract] [Full Text] [Related]
10. Regulatory T cells and EBV associated malignancies.
Li J; Qian CN; Zeng YX
Int Immunopharmacol; 2009 May; 9(5):590-2. PubMed ID: 19539572
[TBL] [Abstract][Full Text] [Related]
11. Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.
Cárdenas Sierra D; Vélez Colmenares G; Orfao de Matos A; Fiorentino Gómez S; Quijano Gómez SM
Clin Exp Immunol; 2014 Jul; 177(1):320-32. PubMed ID: 24666437
[TBL] [Abstract][Full Text] [Related]
12. Functional diversity of the CD8(+) T-cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders.
Nazaruk RA; Rochford R; Hobbs MV; Cannon MJ
Blood; 1998 May; 91(10):3875-83. PubMed ID: 9573025
[TBL] [Abstract][Full Text] [Related]
13. IL-21 Selectively Protects CD62L
Ngai H; Tian G; Courtney AN; Ravari SB; Guo L; Liu B; Jin J; Shen ET; Di Pierro EJ; Metelitsa LS
J Immunol; 2018 Oct; 201(7):2141-2153. PubMed ID: 30111631
[TBL] [Abstract][Full Text] [Related]
14. EBV LMP2A-specific T cell immune responses elicited by dendritic cells loaded with LMP2A protein.
Chen Y; Sun H; Liu G; Wang B; Wang F; Sun B; Yao K
Cell Mol Immunol; 2009 Aug; 6(4):269-76. PubMed ID: 19728928
[TBL] [Abstract][Full Text] [Related]
15. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
16. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.
Wang B; Fujisawa H; Zhuang L; Freed I; Howell BG; Shahid S; Shivji GM; Mak TW; Sauder DN
J Immunol; 2000 Dec; 165(12):6783-90. PubMed ID: 11120799
[TBL] [Abstract][Full Text] [Related]
17. CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs.
Wang C; Liu X; Li Z; Chai Y; Jiang Y; Wang Q; Ji Y; Zhu Z; Wan Y; Yuan Z; Chang Z; Zhang M
Sci Rep; 2015 Sep; 5():14124. PubMed ID: 26369936
[TBL] [Abstract][Full Text] [Related]
18. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs.
Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG
PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769
[TBL] [Abstract][Full Text] [Related]
19. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
